Source: RenalGuard Vimeo Channel

RenalGuard posted a video "Prof. Ponikowski- Late Breaking Clinical Trial Results for Reprieve/RenalGuard Technology for Heart Failure Treatment" on VIMEO

Prof. Ponikowski discusses his results on the use of Guided Diuretic Therapy using Reprieve/RenalGuard technology in acute decompensated heart failure patients, which he presented as a late breaking clinical trial at the European Society of Cardiology's Heart Failure Congress in Vienna, May 2019.The Reprieve Technology is available for investigational use only in the United States.Cast: RenalGuard Solutions

See Video »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jim Dillon's photo - CEO of RenalGuard

CEO

Jim Dillon

CEO Approval Rating

84/100

Read more